Back

The impact of CYP4F2 rs3093135 TT variant on bleeding and thrombosis in dual antiplatelet therapy users.

4 March 2018 (14:00 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Acute Coronary Syndromes (Other) - General Acute Coronary Sydrome Thrombosis, Platelets, and Coagulation ACVC Premium Access Acute Cardiovascular Care 2018

About the speaker

Photo
Mrs Rita Kreckauskiene

Klaipeda University Hospital, Klaipeda (Lithuania)

34 More presentations in this session

Presentation thumbnail
Professor B. Safdar (New Haven, US)
Abstract Slides
Presentation thumbnail
Doctor K. Naeem (Dubai, AE)
Abstract Slides
Presentation thumbnail
Doctor A. Conti (Massa, IT)
Presentation thumbnail
Assistant Professor O. Germanova (Bishkek, KG)
Abstract Slides
Presentation thumbnail
Associate Professor D. Shorikova (Chernivtsi, UA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Acute Coronary Syndromes (Other) - General Acute Coronary Sydrome

The Event

Event poster

Acute Cardiovascular Care 2018

4 March 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy
30 August 2025
thumbnail
Congress Presentation
Allelic polymorphism gene ADP receptor R2RY12 T-744C in patients with HFpEF
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources